# Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male Participants

> **NCT06417229** · PHASE1 · COMPLETED · sponsor: **Celgene** · enrollment: 102 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** BMS-986365
- **DRUG:** Rabeprazole

## Key facts

- **NCT ID:** NCT06417229
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-28
- **Primary completion:** 2025-02-19
- **Final completion:** 2025-02-19
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06417229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06417229, "Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06417229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*